Latest Healthcare Research Reports

Tag: Cell therapy Processing Market Forecast

  • Cell Processing Instruments Market To Witness 7.7% CAGR Growth Through 2030: Key Industry Drivers

    Cell Processing Instruments Market To Witness 7.7% CAGR Growth Through 2030: Key Industry Drivers

    Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

    Cell Processing Instruments Market CAGR Outlook And Future Development

    The cell processing instruments market has shown robust expansion in recent years. Its valuation is anticipated to rise from $6.95 billion in 2025 to $7.51 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.1%. The growth observed in prior periods stemmed from factors such as constrained automation in cell processing, a reliance on manual cell counting and separation techniques, increasing academic and research endeavors, a heightened need for accurate cell analysis, and the introduction of flow cytometry technologies.

    The cell processing instruments market is set to observe significant expansion over the next few years. It is projected to increase to $10.1 billion in 2030, growing at a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period can be ascribed to the progression of integrated cell processing platforms, increasing investments in cell therapy and regenerative medicine, the adoption of digital and automated imaging systems, a rise in contract research and manufacturing activities, and advancements in live cell analysis and high-content screening. Noteworthy trends expected in this period include an escalating demand for automated cell processing systems, the broader uptake of flow cytometry and high-content imaging, growth in cell therapy and regenerative medicine applications, an emphasis on standardization and regulatory adherence, and the integration of multi-functional cell analysis platforms.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=95949961&type=smp&name=Cell%20Processing%20Instruments%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

    Cell Processing Instruments Market Industry Drivers: What’s Behind The Revenue Growth?

    Future expansion of the cell processing instruments market is anticipated, driven by the rising investment in biopharmaceutical research. This research involves the scientific investigation and creation of therapeutic products originating from biological sources or engineered to replicate biological molecules, intended for disease diagnosis, prevention, or treatment. The surge in biopharmaceutical research investment stems from an escalating need for novel therapies to tackle the growing prevalence of chronic diseases and unmet medical requirements, thereby stimulating more extensive research and development endeavors for precise and potent treatments. Cell processing instruments facilitate biopharmaceutical research by providing capabilities for efficient, standardized, and scalable cell manipulation, consequently speeding up the creation and manufacturing of sophisticated cell-based therapies. For example, reports from the BioIndustry Association (BIA), a UK-based trade association, indicated that in January 2025, the UK biotech sector achieved significant growth in 2024, attracting £3.5 billion (approximately $ 4.4 billion) in investment, marking a notable 94% increase compared to the prior year. Consequently, the growing financial commitment to biopharmaceutical research is propelling the expansion of the cell processing instruments market.

    Cell Processing Instruments Market Breakdown By Product Type And Application

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    #Cell Processing Instruments Market Growth Trends: What’s Shaping The Future Outlook?

    Leading companies in the cell processing instruments market are concentrating on devising innovative methods, such as multi-channel asynchronous processing, to elevate workflow efficiency and adaptability in cell therapy development. Multi-channel asynchronous processing defines a system’s capacity to execute multiple distinct workflows simultaneously on separate channels, thereby enabling various processes to operate concurrently without one waiting for another to conclude. For example, in June 2023, Singleron Biotechnologies GmbH, a biotechnology firm based in Germany, introduced two new instruments, Python Junior and Matrix NEO, designed to improve and standardize the single-cell analysis workflow. Python Junior simplifies the dissociation of solid tissues into high-quality single-cell suspensions utilizing dual independent channels and a blend of mechanical and enzymatic processing, whereas Matrix NEO allows for high-throughput, fully automated single-cell library preparation, encompassing chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thus catering to diverse applications and throughput requirements in both research and clinical contexts.

    Cell Processing Instruments Market Company Landscape And Competitive Strategy

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    View The Full Cell Processing Instruments Market Report:

    https://thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

    Cell Processing Instruments Market Largest Region: Which Geography Holds The Biggest Share?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Forecast Reveals Where Future Industry Value Will Be Created

    Cell Therapy Processing Market Forecast Reveals Where Future Industry Value Will Be Created

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Cell Therapy Processing Market Growth From $5.92 Billion In 2026 To $9.93 Billion By 2030 At A CAGR Of 13.8%

    The cell therapy processing sector has experienced substantial expansion recently, with its market value projected to increase from $5.18 billion in 2025 to $5.92 billion in 2026, reflecting a compound annual growth rate of 14.3%. This upward trajectory in the preceding timeframe was driven by a confluence of factors including a surge in clinical trials for cell-based treatments, enhancements in biopharmaceutical production capabilities, the proliferation of dedicated processing infrastructures, a heightened level of proficiency in good manufacturing practice (GMP) adherence, and escalating investments in cutting-edge therapeutic modalities.

    The cell therapy processing market is poised for substantial expansion over the next several years, projecting a rise to $9.93 billion by 2030 with a compound annual growth rate (CAGR) of 13.8%. This projected increase is fueled by several key factors, including the escalating commercial availability of gene and cell therapies, a heightened need for contract manufacturing solutions, the proliferation of distributed manufacturing approaches, wider implementation of digital quality management systems, and an uptick in regulatory endorsements for cell-based therapeutic interventions. Key developments anticipated during this forecast period encompass the greater utilization of GMP-compliant processing platforms, a surge in the demand for adaptable cell therapy production capabilities, increased integration of automated workflow software, the broadening of contract processing services, and a reinforced emphasis on maintaining sterility and assuring quality throughout the manufacturing process.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Cell Therapy Processing Market Demand Drivers: What Is Fueling Industry Growth?

    The proliferation of research endeavors in the realm of cell therapy is anticipated to be a significant catalyst for the expansion of the cell therapy processing market. Cell therapy itself is defined as the production of medicinal products utilizing live cells, aimed at addressing or alleviating a spectrum of ailments such as cancers, autoimmune diseases, and inherited disorders. A key driver behind the escalating demand for cell-based therapeutics is the pressing requirement for manufacturing systems that are both adaptable and dependable, capable of sustaining substantial cell concentrations while preserving the integrity of the final product. The processing of cells plays a crucial role in advancing cell therapy research by facilitating uniform preparation, rigorous quality assurance, and the large-scale production of superior quality cells, thereby guaranteeing dependable and repeatable results for both investigative activities and clinical trials. As an illustration, by December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, an organization headquartered in Switzerland, reported that six novel cell and gene therapies, representing first-in-class innovations, were launched in 2023, a noteworthy increase of 50% compared to the three such treatments launched in 2022. Consequently, the heightened volume of research activities in cell therapy is directly fueling the growth trajectory of the cell therapy processing market.

    Cell Therapy Processing Market Segment Landscape: Which Areas Lead Market Development?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    Cell Therapy Processing Market Innovation Trends: Which Developments Are Transforming The Industry?

    The leading enterprises within the cell therapy processing sector are dedicated to creating sophisticated technologies, for example, combined bioreactor-centrifuge apparatuses, which serve to optimize production sequences and enhance the reliability, adaptability, and aseptic conditions of treatments derived from cells. This integrated bioreactor-centrifuge unit represents a singular piece of equipment merging cell cultivation and centrifugation for separation into one contained module, facilitating uninterrupted, automated cell treatment processes without the necessity of moving cells between different stages. As an illustration, in March of 2025, Limula SA, a firm based in Switzerland specializing in the production of cell and gene therapies (CGT), introduced LimONE, a fully automated, enclosed platform designed for cell therapy production. This pioneering system assimilates physical components, disposable supplies, and software guided by predetermined protocols to simplify intricate cell processing stages, including incubation, centrifugation, and the management of chemical agents, all within a solitary, space-efficient assembly, thereby allowing for uniform, scalable output of therapies like CAR-T and genetically modified stem cells, from initial research phases up to Good Manufacturing Practice (GMP) compliant industrial levels, while circumventing the complexities associated with technology transfers.

    Cell Therapy Processing Market Industry Leaders And Market Competition

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Access The Complete Cell Therapy Processing Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Cell Therapy Processing Market Leading Geography: Which Region Generates The Most Revenue?

    North Americawas the largest region in the cell therapy processing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Forecast Reveals Where Future Industry Value Will Be Created

    Cell Therapy Processing Market Forecast Reveals Where Future Industry Value Will Be Created

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Cell Therapy Processing Market Growth From $5.92 Billion In 2026 To $9.93 Billion By 2030 At A CAGR Of 13.8%

    The cell therapy processing sector has experienced substantial expansion recently, with its market value projected to increase from $5.18 billion in 2025 to $5.92 billion in 2026, reflecting a compound annual growth rate of 14.3%. This upward trajectory in the preceding timeframe was driven by a confluence of factors including a surge in clinical trials for cell-based treatments, enhancements in biopharmaceutical production capabilities, the proliferation of dedicated processing infrastructures, a heightened level of proficiency in good manufacturing practice (GMP) adherence, and escalating investments in cutting-edge therapeutic modalities.

    The cell therapy processing market is poised for substantial expansion over the next several years, projecting a rise to $9.93 billion by 2030 with a compound annual growth rate (CAGR) of 13.8%. This projected increase is fueled by several key factors, including the escalating commercial availability of gene and cell therapies, a heightened need for contract manufacturing solutions, the proliferation of distributed manufacturing approaches, wider implementation of digital quality management systems, and an uptick in regulatory endorsements for cell-based therapeutic interventions. Key developments anticipated during this forecast period encompass the greater utilization of GMP-compliant processing platforms, a surge in the demand for adaptable cell therapy production capabilities, increased integration of automated workflow software, the broadening of contract processing services, and a reinforced emphasis on maintaining sterility and assuring quality throughout the manufacturing process.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Cell Therapy Processing Market Demand Drivers: What Is Fueling Industry Growth?

    The proliferation of research endeavors in the realm of cell therapy is anticipated to be a significant catalyst for the expansion of the cell therapy processing market. Cell therapy itself is defined as the production of medicinal products utilizing live cells, aimed at addressing or alleviating a spectrum of ailments such as cancers, autoimmune diseases, and inherited disorders. A key driver behind the escalating demand for cell-based therapeutics is the pressing requirement for manufacturing systems that are both adaptable and dependable, capable of sustaining substantial cell concentrations while preserving the integrity of the final product. The processing of cells plays a crucial role in advancing cell therapy research by facilitating uniform preparation, rigorous quality assurance, and the large-scale production of superior quality cells, thereby guaranteeing dependable and repeatable results for both investigative activities and clinical trials. As an illustration, by December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, an organization headquartered in Switzerland, reported that six novel cell and gene therapies, representing first-in-class innovations, were launched in 2023, a noteworthy increase of 50% compared to the three such treatments launched in 2022. Consequently, the heightened volume of research activities in cell therapy is directly fueling the growth trajectory of the cell therapy processing market.

    Cell Therapy Processing Market Segment Landscape: Which Areas Lead Market Development?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    Cell Therapy Processing Market Innovation Trends: Which Developments Are Transforming The Industry?

    The leading enterprises within the cell therapy processing sector are dedicated to creating sophisticated technologies, for example, combined bioreactor-centrifuge apparatuses, which serve to optimize production sequences and enhance the reliability, adaptability, and aseptic conditions of treatments derived from cells. This integrated bioreactor-centrifuge unit represents a singular piece of equipment merging cell cultivation and centrifugation for separation into one contained module, facilitating uninterrupted, automated cell treatment processes without the necessity of moving cells between different stages. As an illustration, in March of 2025, Limula SA, a firm based in Switzerland specializing in the production of cell and gene therapies (CGT), introduced LimONE, a fully automated, enclosed platform designed for cell therapy production. This pioneering system assimilates physical components, disposable supplies, and software guided by predetermined protocols to simplify intricate cell processing stages, including incubation, centrifugation, and the management of chemical agents, all within a solitary, space-efficient assembly, thereby allowing for uniform, scalable output of therapies like CAR-T and genetically modified stem cells, from initial research phases up to Good Manufacturing Practice (GMP) compliant industrial levels, while circumventing the complexities associated with technology transfers.

    Cell Therapy Processing Market Industry Leaders And Market Competition

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Access The Complete Cell Therapy Processing Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Cell Therapy Processing Market Leading Geography: Which Region Generates The Most Revenue?

    North Americawas the largest region in the cell therapy processing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Forecast Reveals Where Future Industry Value Will Be Created

    Cell Therapy Processing Market Forecast Reveals Where Future Industry Value Will Be Created

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Cell Therapy Processing Market Growth From $5.92 Billion In 2026 To $9.93 Billion By 2030 At A CAGR Of 13.8%

    The cell therapy processing sector has experienced substantial expansion recently, with its market value projected to increase from $5.18 billion in 2025 to $5.92 billion in 2026, reflecting a compound annual growth rate of 14.3%. This upward trajectory in the preceding timeframe was driven by a confluence of factors including a surge in clinical trials for cell-based treatments, enhancements in biopharmaceutical production capabilities, the proliferation of dedicated processing infrastructures, a heightened level of proficiency in good manufacturing practice (GMP) adherence, and escalating investments in cutting-edge therapeutic modalities.

    The cell therapy processing market is poised for substantial expansion over the next several years, projecting a rise to $9.93 billion by 2030 with a compound annual growth rate (CAGR) of 13.8%. This projected increase is fueled by several key factors, including the escalating commercial availability of gene and cell therapies, a heightened need for contract manufacturing solutions, the proliferation of distributed manufacturing approaches, wider implementation of digital quality management systems, and an uptick in regulatory endorsements for cell-based therapeutic interventions. Key developments anticipated during this forecast period encompass the greater utilization of GMP-compliant processing platforms, a surge in the demand for adaptable cell therapy production capabilities, increased integration of automated workflow software, the broadening of contract processing services, and a reinforced emphasis on maintaining sterility and assuring quality throughout the manufacturing process.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Cell Therapy Processing Market Demand Drivers: What Is Fueling Industry Growth?

    The proliferation of research endeavors in the realm of cell therapy is anticipated to be a significant catalyst for the expansion of the cell therapy processing market. Cell therapy itself is defined as the production of medicinal products utilizing live cells, aimed at addressing or alleviating a spectrum of ailments such as cancers, autoimmune diseases, and inherited disorders. A key driver behind the escalating demand for cell-based therapeutics is the pressing requirement for manufacturing systems that are both adaptable and dependable, capable of sustaining substantial cell concentrations while preserving the integrity of the final product. The processing of cells plays a crucial role in advancing cell therapy research by facilitating uniform preparation, rigorous quality assurance, and the large-scale production of superior quality cells, thereby guaranteeing dependable and repeatable results for both investigative activities and clinical trials. As an illustration, by December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, an organization headquartered in Switzerland, reported that six novel cell and gene therapies, representing first-in-class innovations, were launched in 2023, a noteworthy increase of 50% compared to the three such treatments launched in 2022. Consequently, the heightened volume of research activities in cell therapy is directly fueling the growth trajectory of the cell therapy processing market.

    Cell Therapy Processing Market Segment Landscape: Which Areas Lead Market Development?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    Cell Therapy Processing Market Innovation Trends: Which Developments Are Transforming The Industry?

    The leading enterprises within the cell therapy processing sector are dedicated to creating sophisticated technologies, for example, combined bioreactor-centrifuge apparatuses, which serve to optimize production sequences and enhance the reliability, adaptability, and aseptic conditions of treatments derived from cells. This integrated bioreactor-centrifuge unit represents a singular piece of equipment merging cell cultivation and centrifugation for separation into one contained module, facilitating uninterrupted, automated cell treatment processes without the necessity of moving cells between different stages. As an illustration, in March of 2025, Limula SA, a firm based in Switzerland specializing in the production of cell and gene therapies (CGT), introduced LimONE, a fully automated, enclosed platform designed for cell therapy production. This pioneering system assimilates physical components, disposable supplies, and software guided by predetermined protocols to simplify intricate cell processing stages, including incubation, centrifugation, and the management of chemical agents, all within a solitary, space-efficient assembly, thereby allowing for uniform, scalable output of therapies like CAR-T and genetically modified stem cells, from initial research phases up to Good Manufacturing Practice (GMP) compliant industrial levels, while circumventing the complexities associated with technology transfers.

    Cell Therapy Processing Market Industry Leaders And Market Competition

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Access The Complete Cell Therapy Processing Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Cell Therapy Processing Market Leading Geography: Which Region Generates The Most Revenue?

    North Americawas the largest region in the cell therapy processing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Processing Instruments Market Growth Is Reshaping Competitive Advantage Across The Industry

    Cell Processing Instruments Market Growth Is Reshaping Competitive Advantage Across The Industry

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    The cell processing instruments market has been showing remarkable growth recently, driven by advancements in technology and increasing applications in biopharmaceutical research and cell therapy. As the industry evolves, it is expected to witness continued expansion fueled by automation and innovation. Below is a detailed overview of the market size, growth drivers, key segments, emerging trends, competitive landscape, and regional insights shaping its future.

    Steady Growth in Market Size for Cell Processing Instruments

    The cell processing instruments market has experienced substantial growth over recent years. It is projected to increase from $6.95 billion in 2025 to $7.51 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.1%. Historically, this expansion has been driven by limited automation in cell processing workflows, reliance on manual methods for cell counting and separation, a surge in academic and research activities, growing demand for precise cell analysis, and the rise of flow cytometry technologies.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Expectations for Continued Expansion Through 2030

    Looking ahead, the market is forecasted to grow strongly, reaching $10.1 billion by 2030 with a CAGR of 7.7%. This anticipated rise is attributed to the advancement of integrated cell processing platforms, increased funding in cell therapy and regenerative medicine, wider adoption of digital and automated imaging systems, growth in contract research and manufacturing activities, and progress in live cell analysis and high-content screening. Key trends shaping the market include the growing preference for automated cell processing systems, expanded use of flow cytometry and high-content imaging, rising applications in regenerative medicine, a focus on standardization and regulatory compliance, and the integration of multifunctional cell analysis platforms.

    Increasing Investment in Biopharmaceutical Research as a Growth Catalyst

    The surge in investment within biopharmaceutical research is set to significantly drive the cell processing instruments market forward. Biopharmaceutical research focuses on the development of therapeutic products derived from biological sources or designed to replicate biological molecules, aimed at diagnosing, preventing, or treating various diseases. Growing demand for innovative therapies to combat chronic illnesses and address unmet medical needs has fueled increased research and development activities targeting more effective treatments.

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Cell Processing Instruments Market Largest Region By Revenue And Market Share

    How Cell Processing Instruments Support Biopharmaceutical Advancements

    Cell processing instruments play a crucial role in biopharmaceutical research by enabling efficient, standardized, and scalable cell handling. This capability accelerates the advancement and production of sophisticated cell-based therapies. For example, in January 2025, the UK’s BioIndustry Association reported that the UK biotech sector achieved substantial growth in 2024, securing £3.5 billion (approximately $4.4 billion) in investment—an impressive 94% increase from the prior year. Such robust investment trends are propelling growth within the cell processing instruments market.

    Comprehensive Segmentation of the Cell Processing Instruments Market

    The market is segmented based on type, application, and end-use.

    By type, the categories include Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Other Instruments.

    Applications cover Cell Isolation or Separation, Cell Imaging and Counting, Cell Viability and Proliferation, and Other Uses.

    End-users consist of Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), Academic and Research Institutes, and additional sectors.

    Detailed Breakdown of Subsegments

    Further classification involves:

    – Cell Counters: Manual, Automated, and Digital.

    – Cell Imaging Systems: Brightfield, Fluorescence, High-Content, and Live Cell Imaging.

    – Flow Cytometers: Analog, Digital, Benchtop, and Clinical models.

    – Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS), Fluorescence-Activated Cell Sorting (FACS), and Centrifugal Elutriation.

    – Automated Cell Processing Systems: Cell Expansion, Cell Washing and Concentration, Cell Harvesting, and Integrated Platforms.

    – Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges for Cell Processing, and Cell Freezing and Thawing Systems.

    Innovative Trends Advancing the Cell Processing Instruments Market

    Leading companies are focusing on novel innovations such as multi-channel asynchronous processing, which enhances efficiency and flexibility by enabling simultaneous independent workflows on different channels. This technology supports the parallel operation of various processes without delays. For instance, in June 2023, Germany-based Singleron Biotechnologies GmbH introduced two new instruments—Python Junior and Matrix NEO—to streamline and standardize single-cell analysis. Python Junior facilitates the dissociation of solid tissues into high-quality single-cell suspensions using dual channels and combined mechanical and enzymatic approaches, while Matrix NEO provides high-throughput, fully automated single-cell library preparation across four channels, serving diverse research and clinical needs.

    Key Players Leading the Cell Processing Instruments Market

    The competitive landscape features several prominent companies, including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., and InGeneron Inc.

    Regional Market Leadership and Growth Prospects

    In 2025, North America was the largest revenue contributor to the cell processing instruments market. Meanwhile, the Asia-Pacific region is projected to experience the fastest growth during the forecast period. The market analysis also includes regions such as South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a broad perspective on global market dynamics.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Increasing Investment In Biopharmaceutical Research Is Fueling The Growth Of The Market Due To Rising Demand For Advanced And Scalable Cell-Based Therapy Development Continues To Impact The Growth Of The Cell Processing Instruments Market

    Increasing Investment In Biopharmaceutical Research Is Fueling The Growth Of The Market Due To Rising Demand For Advanced And Scalable Cell-Based Therapy Development Continues To Impact The Growth Of The Cell Processing Instruments Market

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    By 2030, How Much Growth In Market Size Is Expected For The Cell Processing Instruments Market?

    The cell processing instruments market has experienced significant expansion in recent years. This market is forecast to grow from $6.95 billion in 2025 to $7.51 billion in 2026, at a compound annual growth rate (CAGR) of 8.1%. The historical growth of this market can be attributed to factors such as the limited automation in cell processing, the dependence on manual cell counting and separation methods, expanding academic and research activities, an escalating demand for accurate cell analysis, and the advent of flow cytometry technologies.

    The cell processing instruments market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $10.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This projected growth during the forecast period can be credited to factors such as the evolution of integrated cell processing platforms, increasing capital allocation towards cell therapy and regenerative medicine, the embrace of digital and automated imaging solutions, a surge in contract research and manufacturing operations, and progress in live cell analysis and high-content screening technologies. Key developments expected during this timeframe include a heightened need for automated cell processing systems, broader implementation of flow cytometry and high-content imaging, the expansion of cell therapy and regenerative medicine applications, a focus on achieving standardization and regulatory adherence, and the incorporation of multi-functional cell analysis platforms.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Strategic Drivers Are Supporting The Cell Processing Instruments Market Development?

    The cell processing instruments market is anticipated to expand due to rising investments in biopharmaceutical research. Biopharmaceutical research encompasses the scientific investigation and creation of therapeutic products derived from biological sources or designed to mimic biological molecules, intended for disease diagnosis, prevention, or treatment. This surge in investment is driven by an escalating need for innovative therapies to address the growing prevalence of chronic diseases and unmet medical needs, thereby fostering greater research and development efforts for targeted, effective treatments. Cell processing instruments aid biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which in turn accelerates the development and production of advanced cell-based therapies. For example, in January 2025, the BioIndustry Association (BIA), a UK-based trade association, reported that the UK biotech sector experienced substantial growth in 2024, attracting £3.5 billion (approximately $ 4.4 billion) in investment, marking a significant 94% increase from the previous year. Consequently, the expanding financial commitment to biopharmaceutical research is fueling the growth of the cell processing instruments market.

    How Is The Cell Processing Instruments Market Structured Across Different Market Segments?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    What Trends Are Affecting The Growth Of The Cell Processing Instruments Market?

    Leading companies in the cell processing instruments market are focusing on developing innovative strategies, such as multi-channel asynchronous processing, to improve workflow efficiency and flexibility in cell therapy development. Multi-channel asynchronous processing refers to a system’s capacity to run multiple independent workflows simultaneously on separate channels, allowing various processes to proceed in parallel without waiting for each other’s completion. For instance, in June 2023, Singleron Biotechnologies GmbH, a Germany-based biotechnology company, launched two new instruments, Python Junior and Matrix NEO, to enhance and standardize the single-cell analysis workflow. Python Junior streamlines the dissociation of solid tissues into high-quality single-cell suspensions using dual independent channels and a mix of mechanical and enzymatic processing, while Matrix NEO enables high-throughput, fully automated single-cell library preparation, including chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, supporting a range of applications and throughput levels in both research and clinical environments.

    Which Companies Are Engaged In The Cell Processing Instruments Market Environment?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Access The Complete Cell Processing Instruments Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Region Leads The Cell Processing Instruments Market By Size?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Customized Cell Processing Instruments Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell therapy processing market to reach $9.93B by 2030 at 13.8% CAGR

    Cell therapy processing market to reach $9.93B by 2030 at 13.8% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Will The Market Value Of The Cell Therapy Processing Market Progress Between 2026 And 2030?

    The cell therapy processing market size has experienced rapid expansion over recent years. It is anticipated to increase from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. Historically, this growth can be linked to an increase in clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and heightened investment in advanced therapeutics.

    The cell therapy processing market is projected for substantial expansion in the coming years, with its size anticipated to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This projected growth is driven by factors such as the expanding commercialization of gene and cell therapies, a heightened demand for contract manufacturing services, the proliferation of decentralized manufacturing approaches, an increasing uptake of digital quality management systems, and a rise in regulatory approvals for cell-based treatments. Key trends expected during this period involve the greater adoption of GMP-compliant processing platforms, an escalating need for scalable cell therapy manufacturing, the wider integration of workflow automation software, a broadening of contract processing services, and an intensified emphasis on maintaining sterility and ensuring quality.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Major Drivers Are Influencing The Expansion Of The Cell Therapy Processing Market?

    An anticipated increase in cell therapy research initiatives is set to fuel the expansion of the cell therapy processing market. Cell therapy involves creating therapeutic agents from living cells to address or manage diverse illnesses such as cancers, autoimmune conditions, and genetic ailments. The increasing need for consistent and scalable manufacturing platforms capable of handling high cell densities without affecting product quality is contributing to the heightened demand for cell-based therapies. For cell therapy research, cell therapy processing proves advantageous by allowing for the standardized preparation, quality assurance, and mass production of high-quality cells, thereby guaranteeing dependable and consistent results for both experimental and clinical investigations. An illustrative example is from December 2024, where the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, reported that six novel cell and gene therapies were launched in 2023, representing a 50% increase over the three introduced in 2022. Consequently, the expanding volume of cell therapy research activities is a key driver for the growth of the cell therapy processing market.

    What Segment Categories Shape The Cell Therapy Processing Market Segment Landscape?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    Which Trends Are Shaping The Cell Therapy Processing Market?

    Leading companies in the cell therapy processing market are concentrating on creating advanced solutions, particularly integrated bioreactor-centrifuge systems. These innovations aim to streamline manufacturing processes and improve the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system operates as a combined unit, incorporating cell incubation and centrifugal separation within a single, sealed environment. This enables continuous, automated cell processing without requiring intermediate transfers. For instance, in March 2025, Limula SA, a Switzerland-based company focused on cell and gene therapy (CGT), introduced LimONE. This automated, closed-system platform for cell therapy manufacturing brings together hardware, single-use consumables, and protocol-driven software. It condenses complex cell processing steps, such as incubation, centrifugation, and reagent handling, into one compact device, supporting the consistent and scalable production of therapies like CAR-T and gene-edited stem cells from research stages up to GMP-compliant manufacturing, without complex technology transfers.

    Who Are The Companies Operating Across The Cell Therapy Processing Market Value Chain?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Get The Full Cell Therapy Processing Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Holds The Highest Market Share In The Cell Therapy Processing Market?

    North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Cell Therapy Processing Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

    Exterior Insulation And Finish System Market Report 2026

    https://www.thebusinessresearchcompany.com/report/exterior-insulation-and-finish-system-global-market-report

    Metal Structural Insulation Panels Market Report 2026

    https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

    Vacuum Insulation Panel Market Report 2026

    https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Cell Processing Instruments Market Between 2026 And 2030?

    The cell processing instruments market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $6.95 billion in 2025 to $7.51 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.1%. Historically, this growth can be ascribed to several factors, including the previous lack of automation in cell processing, a dependence on manual cell counting and separation techniques, an escalation in academic and research activities, a heightened requirement for precise cell analysis, and the emergence of flow cytometry technologies.

    The cell processing instruments market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $10.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth is primarily driven by the development of integrated cell processing platforms, increasing investment in cell therapy and regenerative medicine, the adoption of digital and automated imaging systems, a rise in contract research and manufacturing activities, and advancements in live cell analysis and high-content screening. Furthermore, significant trends for this period include a heightened demand for automated cell processing systems, the growing adoption of flow cytometry and high-content imaging, the expansion of cell therapy and regenerative medicine applications, an emphasis on standardization and regulatory compliance, and the integration of multi-functional cell analysis platforms.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Strong Drivers Are Impacting The Cell Processing Instruments Market Growth?

    The increasing investment in biopharmaceutical research is expected to propel the growth of the cell processing instruments market going forward. Biopharmaceutical research refers to the scientific study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for diagnosing, preventing, or treating diseases. The growing demand for innovative therapies to address rising chronic diseases and unmet medical needs is driving this increasing investment, prompting greater research and development efforts for targeted, effective treatments. Cell processing instruments support biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which accelerates the development and production of advanced cell-based therapies. For instance, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector experienced substantial growth in 2024, securing £3.5 billion (approximately $ 4.4 billion) in investment, an impressive 94% increase from the previous year. Therefore, the increasing investment in biopharmaceutical research is driving the growth of the cell processing instruments market.

    How Is The Cell Processing Instruments Market Categorized Across Its Segment Groups?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Trends Are Contributing To Changes In The Cell Processing Instruments Market?

    Companies within the cell processing instruments market are prioritizing the creation of advanced methods, including multi-channel asynchronous processing, to elevate workflow effectiveness and flexibility in cell therapy development. Multi-channel asynchronous processing provides a system with the capacity to run multiple separate workflows simultaneously on distinct channels, allowing different operations to proceed in parallel without needing to wait for one another. As an illustration, in June 2023, Singleron Biotechnologies GmbH, a German biotechnology company, unveiled two new instruments, Python Junior and Matrix NEO, designed to refine and standardize the single-cell analysis workflow. Python Junior facilitates the dissociation of solid tissues into premium single-cell suspensions using dual independent channels through a blend of mechanical and enzymatic processing, whereas Matrix NEO allows for high-throughput, fully automated single-cell library preparation, covering chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby accommodating various applications and throughput requirements in both research and clinical settings.

    Which Firms Are Influencing Competition In The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Get The Full Cell Processing Instruments Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Geographic Region Dominates The Cell Processing Instruments Market?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Cell Processing Instruments Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Cell Processing Instruments Market Between 2026 And 2030?

    The cell processing instruments market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $6.95 billion in 2025 to $7.51 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.1%. Historically, this growth can be ascribed to several factors, including the previous lack of automation in cell processing, a dependence on manual cell counting and separation techniques, an escalation in academic and research activities, a heightened requirement for precise cell analysis, and the emergence of flow cytometry technologies.

    The cell processing instruments market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $10.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth is primarily driven by the development of integrated cell processing platforms, increasing investment in cell therapy and regenerative medicine, the adoption of digital and automated imaging systems, a rise in contract research and manufacturing activities, and advancements in live cell analysis and high-content screening. Furthermore, significant trends for this period include a heightened demand for automated cell processing systems, the growing adoption of flow cytometry and high-content imaging, the expansion of cell therapy and regenerative medicine applications, an emphasis on standardization and regulatory compliance, and the integration of multi-functional cell analysis platforms.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Strong Drivers Are Impacting The Cell Processing Instruments Market Growth?

    The increasing investment in biopharmaceutical research is expected to propel the growth of the cell processing instruments market going forward. Biopharmaceutical research refers to the scientific study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for diagnosing, preventing, or treating diseases. The growing demand for innovative therapies to address rising chronic diseases and unmet medical needs is driving this increasing investment, prompting greater research and development efforts for targeted, effective treatments. Cell processing instruments support biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which accelerates the development and production of advanced cell-based therapies. For instance, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector experienced substantial growth in 2024, securing £3.5 billion (approximately $ 4.4 billion) in investment, an impressive 94% increase from the previous year. Therefore, the increasing investment in biopharmaceutical research is driving the growth of the cell processing instruments market.

    How Is The Cell Processing Instruments Market Categorized Across Its Segment Groups?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Trends Are Contributing To Changes In The Cell Processing Instruments Market?

    Companies within the cell processing instruments market are prioritizing the creation of advanced methods, including multi-channel asynchronous processing, to elevate workflow effectiveness and flexibility in cell therapy development. Multi-channel asynchronous processing provides a system with the capacity to run multiple separate workflows simultaneously on distinct channels, allowing different operations to proceed in parallel without needing to wait for one another. As an illustration, in June 2023, Singleron Biotechnologies GmbH, a German biotechnology company, unveiled two new instruments, Python Junior and Matrix NEO, designed to refine and standardize the single-cell analysis workflow. Python Junior facilitates the dissociation of solid tissues into premium single-cell suspensions using dual independent channels through a blend of mechanical and enzymatic processing, whereas Matrix NEO allows for high-throughput, fully automated single-cell library preparation, covering chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby accommodating various applications and throughput requirements in both research and clinical settings.

    Which Firms Are Influencing Competition In The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Get The Full Cell Processing Instruments Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Geographic Region Dominates The Cell Processing Instruments Market?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Cell Processing Instruments Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Cell Processing Instruments Market Between 2026 And 2030?

    The cell processing instruments market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $6.95 billion in 2025 to $7.51 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.1%. Historically, this growth can be ascribed to several factors, including the previous lack of automation in cell processing, a dependence on manual cell counting and separation techniques, an escalation in academic and research activities, a heightened requirement for precise cell analysis, and the emergence of flow cytometry technologies.

    The cell processing instruments market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $10.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth is primarily driven by the development of integrated cell processing platforms, increasing investment in cell therapy and regenerative medicine, the adoption of digital and automated imaging systems, a rise in contract research and manufacturing activities, and advancements in live cell analysis and high-content screening. Furthermore, significant trends for this period include a heightened demand for automated cell processing systems, the growing adoption of flow cytometry and high-content imaging, the expansion of cell therapy and regenerative medicine applications, an emphasis on standardization and regulatory compliance, and the integration of multi-functional cell analysis platforms.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Strong Drivers Are Impacting The Cell Processing Instruments Market Growth?

    The increasing investment in biopharmaceutical research is expected to propel the growth of the cell processing instruments market going forward. Biopharmaceutical research refers to the scientific study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for diagnosing, preventing, or treating diseases. The growing demand for innovative therapies to address rising chronic diseases and unmet medical needs is driving this increasing investment, prompting greater research and development efforts for targeted, effective treatments. Cell processing instruments support biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which accelerates the development and production of advanced cell-based therapies. For instance, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector experienced substantial growth in 2024, securing £3.5 billion (approximately $ 4.4 billion) in investment, an impressive 94% increase from the previous year. Therefore, the increasing investment in biopharmaceutical research is driving the growth of the cell processing instruments market.

    How Is The Cell Processing Instruments Market Categorized Across Its Segment Groups?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Trends Are Contributing To Changes In The Cell Processing Instruments Market?

    Companies within the cell processing instruments market are prioritizing the creation of advanced methods, including multi-channel asynchronous processing, to elevate workflow effectiveness and flexibility in cell therapy development. Multi-channel asynchronous processing provides a system with the capacity to run multiple separate workflows simultaneously on distinct channels, allowing different operations to proceed in parallel without needing to wait for one another. As an illustration, in June 2023, Singleron Biotechnologies GmbH, a German biotechnology company, unveiled two new instruments, Python Junior and Matrix NEO, designed to refine and standardize the single-cell analysis workflow. Python Junior facilitates the dissociation of solid tissues into premium single-cell suspensions using dual independent channels through a blend of mechanical and enzymatic processing, whereas Matrix NEO allows for high-throughput, fully automated single-cell library preparation, covering chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby accommodating various applications and throughput requirements in both research and clinical settings.

    Which Firms Are Influencing Competition In The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Get The Full Cell Processing Instruments Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Geographic Region Dominates The Cell Processing Instruments Market?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Cell Processing Instruments Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model